SCM
AH

Stevens Capital Management’s Accretive Health AH Stock Holding History

Stevens Capital Management’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-30,557
Closed -$279K – 1416
2013
Q3 		$279K Buy
30,557
+18,319
+150% +$182K 0.01% 813
2013
Q2 		$132K Buy
+12,238
New +$129K ﹤0.01% 846

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CII
CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return

Stevens Capital Management's AH Position: Q4 2013 in Review

Stevens Capital Management sold out of Accretive Health (AH) in Q4 2013, closing a stake of 30,557 shares — an estimated $279K sold.

Stevens Capital Management first reported a position in AH in Q2 2013 and held it in 2 quarters. The position peaked at $279K in Q3 2013. 85 funds tracked by Wall St. Rank hold AH as of Q4 2013.

  • Stevens Capital Management reported no remaining Accretive Health position as of Q4 2013 after selling out during the quarter.
  • Stevens Capital Management sold 30,557 Accretive Health shares in Q4 2013, an estimated $279K.
  • Stevens Capital Management first reported a position in Accretive Health in Q2 2013 and held it in 2 quarters.
  • Stevens Capital Management's Accretive Health position peaked at $279K in Q3 2013.
  • 85 funds tracked by Wall St. Rank held Accretive Health as of Q4 2013.

Based on Stevens Capital Management's 13F filing for Q4 2013, filed 6 Feb 2014.